https://www.selleckchem.com/products/bptes.html
To understand medication, lifestyle, and clinical care changes by persons with RA during the first months (March through May 202 of the COVID-19 pandemic in the US. Data were provided by adults with RA participating in FORWARD, The National Databank for Rheumatic Diseases, observational registry who answered COVID-19 web-based surveys in May 2020 and previously provided baseline (pre-COVID) characteristics and medication use. We compared medication changes by DMARD exposure in logistic models adjusting for age, sex, comorbidities includ
Aimer
Commentaire
Partagez
